Targeting Fn14 with mAb 002 or by genetic deletion was able to prevent the increased uptake of [18F]FDG in C26, demonstrating that the Fn14 receptor is linked to the glucose metabolic pathway of tumours. Here, TNFRSF12A is linked to neoplasm.